Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Summit (11)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Artificial Intelligence (10)
- Big Data (11)
- Bioenergy (45)
- Biology (73)
- Biomedical (17)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (12)
- Climate Change (42)
- Composites (5)
- Computer Science (22)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (91)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (21)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (10)
- Materials (12)
- Materials Science (6)
- Mathematics (5)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Neutron Science (4)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (15)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight